Showing 15,781 - 15,800 results of 99,324 for search '(( 5 ((((ng decrease) OR (nn decrease))) OR (a decrease)) ) OR ( 5 point decrease ))', query time: 1.39s Refine Results
  1. 15781
  2. 15782

    The data of meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  3. 15783

    Quality assessment for risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  4. 15784

    Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  5. 15785

    The results of safety in meta-analysis. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  6. 15786

    Graphs of risk of bias for studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  7. 15787

    General baseline of included studies. by Fei Lin (156666)

    Published 2023
    “…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”
  8. 15788
  9. 15789

    IQGAP1 is a protein that plays a critical role in regulating the level of apoptosis in endothelial cells. by Shaojun Huang (12489901)

    Published 2025
    “…<p>(A) The Annexin V–FITC/propidium iodide (PI) assay results indicate that Si-IQGAP1 can slightly decrease the apoptosis rate of normal cells, whereas knocking down IQGAP1 in PA-induced cells (PA + Si-IQGAP1) can significantly reduce the apoptosis rate. …”
  10. 15790
  11. 15791

    An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals by Dominique Detaille (3768979)

    Published 2019
    “…<div><p>Findings</p><p>Here, we demonstrate that OP2113 (5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione, CAS 532-11-6), synthesized and used as a drug since 1696, does not act as an unspecific antioxidant molecule (i.e., as a radical scavenger) but unexpectedly decreases mitochondrial reactive oxygen species (ROS/H<sub>2</sub>O<sub>2</sub>) production by acting as a specific inhibitor of ROS production at the I<sub>Q</sub> site of complex I of the mitochondrial respiratory chain. …”
  12. 15792
  13. 15793
  14. 15794
  15. 15795
  16. 15796
  17. 15797
  18. 15798
  19. 15799
  20. 15800

    Microstructure Evolution of the Mg-5.8 Zn-0.5 Zr-1.0 Yb Alloy During Homogenization by Lu Li (14069)

    Published 2022
    “…After homogenization, most of the eutectic phases dissolve into the matrix, except for a small amount of Mg-Zn-Yb phase. The area fractions of residual secondary phase decrease from 5.54% in the as-cast alloy to 0.59% in the well-homogenized sample. …”